CCL vs LYEL · P/E 15, rev $12.83B vs rev $6.0K
Carnival Corporation (CCL) versus Lyell Immunopharma Inc (LYEL) — a side-by-side from cached financials, not a winner call.
Carnival Corporation (CCL) is a travel services company listed on US.
Lyell Immunopharma Inc (LYEL) is a biotechnology company listed on US.
Latest reported CCL revenue for 2026-05-31 was $12.83B. Net income was $795.0M. CCL currently screens at market cap $39.74B and trailing P/E 15.3.
Latest reported LYEL revenue for 2026-06-30 was $6.0K. Net income was -$68.9M. LYEL currently screens at market cap $143.5M.
CCL currently screens at market cap $39.74B and trailing P/E 15.3. LYEL currently screens at market cap $143.5M.
Not investment advice. Open the CCL and LYEL stock pages for the full models.
Not investment advice.